In the AD mice, activation of Gpbar1 with tauroursodeoxycholic acid (TUDCA) triggers the AKT/GSK3β pathway to exert anti-inflammatory effects [48,49]. The gene discussed is GPBAR1; the disease is Alzheimer disease.